Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that its collaboration to develop treatments…
pthomsonJanuary 20, 2022
Taking brain research in promising new directions is at the heart of a new Simon…
pthomsonJanuary 19, 2022
At some B.C. COVID-19 vaccine clinics, including the province’s largest at the Vancouver Convention Centre,…
pthomsonJanuary 18, 2022
This week we profile a recent publication in Development from Matthew Shannon in Dr. Alexander…
pthomsonJanuary 18, 2022
A COVID-19 treatment developed in partnership between Vancouver biotech AbCellera Biologics Inc. (Nasdaq:ABCL) and U.S.…
pthomsonJanuary 17, 2022
Congratulations to the BC Children’s Hospital Research Institute (BCCHR) investigators and their teams who were…
pthomsonJanuary 17, 2022
Many pregnancy disorders, including early-onset preeclampsia (EOPE), are associated with defects in placental trophoblast cell…
pthomsonJanuary 14, 2022
A record amount of money is spent developing new drugs, but drug approval rates are…
sciencecityApril 11, 2017
B.C. billionaire Jim Pattison has donated $75 million to the St. Paul's Hospital Foundation in Vancouver.…
sciencecityApril 10, 2017
STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells
STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells STEMCELL…
sciencecityApril 6, 2017
Autism Spectrum Disorders (ASDs) are defined by significant challenges with communication, social reciprocity, and structured…
sciencecityApril 5, 2017
New UBC research on bacteria that cause major problems for those with cystic fibrosis reveals…
sciencecityApril 4, 2017
UBC scientists have scanned the genome of cannabis plants to find the genes responsible for…
sciencecityApril 3, 2017
Imagine if before taking a medication, you could walk into your local pharmacy and take…
sciencecityMarch 31, 2017
